Viewing Study NCT00003532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 7:21 PM
Study NCT ID: NCT00003532
Status: TERMINATED
Last Update Posted: 2017-12-12
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Sponsor: Burzynski Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Ovarian Cancer View
None Stage IV Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stage III ovarian epithelial cancer View
None Stage IV ovarian epithelial cancer View
None Stage III ovarian germ cell tumor View
None Stage IV ovarian germ cell tumor View